Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT01250223 |
Date of registration:
|
26/11/2010 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
|
Scientific title:
|
F2-PROTOCOL: Prospective Collection of Data of Possible Prognostic Relevance in Patients With Follicular Lymphoma |
Date of first enrolment:
|
February 2003 |
Target sample size:
|
1093 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01250223 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Argentina
|
Czech Republic
|
Czechia
|
France
|
Italy
|
Spain
|
Switzerland
|
United Kingdom
|
United States
| | | | | | | |
Contacts
|
Name:
|
Peter McLaughlin, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
UT MD Anderson Cancer Ctr, Houston, TX, USA |
|
Name:
|
Armando Lopez-Guillermo, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Institut d'Hematologia i Oncologia, Hospital Clinic, Barcelona, Spain |
|
Name:
|
Massimo Federico, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Dip. Oncologia, Ematologia e Patologie dell'Apparato Respiratorio - Università di Modena e Reggio Emilia, Modena, Italy |
|
Name:
|
Umberto Vitolo, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Azienda Universitaria Ospedaliera San Giovanni Battista, Torino, Italy |
|
Name:
|
Philippe Solal-Céligny, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Centre Jean Bernard, Le Mans, France |
|
Name:
|
Stefano A. Pileri, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Instituto Seragnoli, Unità Operativa di Emolinfopatologia, Università di Bologna, Bologna, Italy |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with newly diagnosed follicular lymphoma
- Patients with histologically confirmed diagnosis of follicular lymphoma according to
WHO classification (any grade)
- Age over 18
- Written informed consent
Exclusion Criteria:
- None
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Lymphoma, Follicular
|
Primary Outcome(s)
|
Progression Free Survival (PFS)
[Time Frame: 5-year]
|
Secondary Outcome(s)
|
Event Free Survival (EFS)
[Time Frame: 5-year]
|
Treatment Free Survival
[Time Frame: 5-year]
|
Overall Survival (OS)
[Time Frame: 5-year]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|